Ireland
--:--IST
Priya Life Science Medicines register
Registers› Irish medicines ›Plenvu powder for oral solution
Medicines register · Ireland

Plenvu powder for oral solution

Authorisation PA1336/005/001 · Norgine B.V.

Source: Health Products Regulatory Authority (HPRA), open dataset, CC BY 4.0. HPRA list dated 19 Nov 2026
Licence holder
Norgine B.V. (all products →)
Active substances
Macrogol 3350, Sodium sulfate anhydrous, Sodium chloride, Potassium chloride, Macrogol 3350, Sodium chloride, Potassium chloride, Sodium ascorbate, Ascorbic acid
Clinical trials
3 clinical trials → 3 clinical trials → 2 clinical trials →
Dosage form
Powder for oral solution
Route of administration
Oral use
ATC codes
A06AD, A06AD65
First authorised
01/12/2017
Prescription status
Product subject to prescription which may be renewed (B)
Supply
Supply through pharmacies only
Legal basis
Fixed combination application (Article 10b of Directive No 2001/83/EC)

Macrogol 3350: supply and approvals

19 authorised products on the HPRA list contain Macrogol 3350. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 18 Nov 2026)
US shortage (FDA)
No entry in the FDA drug shortage list (checked 18 Nov 2026)
Germany (BfArM)
No entry in the BfArM supply notices (checked 18 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

Sodium sulfate anhydrous: supply and approvals

126 authorised products on the HPRA list contain Sodium sulfate anhydrous. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 18 Nov 2026)
US shortage (FDA)
Sodium Acetate Injection: in shortage, updated 15 Nov 2026
Germany (BfArM)
No entry in the BfArM supply notices (checked 18 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

Sodium chloride: supply and approvals

126 authorised products on the HPRA list contain Sodium chloride. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 18 Nov 2026)
US shortage (FDA)
Sodium Acetate Injection: in shortage, updated 15 Nov 2026
Germany (BfArM)
No entry in the BfArM supply notices (checked 18 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

About this licence

National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 8 years (since 1 December 2017). The HPRA list marks it as marketed in Ireland.

Other medicines with Macrogol 3350 in Ireland

18 other products on the HPRA list contain Macrogol 3350, from 9 licence holders; 7 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Laxido Orange, powder for oral solutionGalen Pharma Ireland LimitedNational authorisation (PA)Marketed
Laxido Paediatric Plain, 6.9 g sachet, powder for oral solutionGalen Pharma Ireland LimitedNational authorisation (PA)Marketed
Macrolief 13.8g sachet, powder for oral solutionRowex Limited,National authorisation (PA)Marketed
Molaxole powder for oral solutionViatris Healthcare LimitedNational authorisation (PA)Marketed
Movicol 13.8 g sachet powder for oral solutionNorgine Healthcare B.V.National authorisation (PA)Marketed
Movicol Paediatric Plain 6.9 g sachet powder for oral solutionNorgine Healthcare B.V.National authorisation (PA)Marketed
Moviprep, powder for oral solutionNorgine B.V.National authorisation (PA)Marketed
Laxido, powder for oral solutionGalen Pharma Ireland LimitedNational authorisation (PA)Not marketed
MOVIPREP, powder for oral solutionPCO Manufacturing Ltd.Parallel import (PPA)Not stated
Movicol Paediatric Chocolate Flavour 6.9 g sachet powder for oral solutionNorgine Healthcare B.V.National authorisation (PA)Not marketed
Movicol 13.8g sachet, powder for oral solutionNovalus Healthcare LimitedParallel import (PPA)Not stated
Movicol Chocolate 13.9 g sachet powder for oral solutionNorgine Healthcare B.V.National authorisation (PA)Not marketed

All 19 products with Macrogol 3350 →

Other medicines with Sodium sulfate anhydrous in Ireland

3 other products on the HPRA list contain Sodium sulfate anhydrous, from 2 licence holders; 1 of them is marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Moviprep, powder for oral solutionNorgine B.V.National authorisation (PA)Marketed
Moviprep Orange, powder for oral solutionNorgine B.V.National authorisation (PA)Not marketed
Moviprep, powder for oral solutionIMED Healthcare Ltd.,Parallel import (PPA)Not stated

Other substances in ATC group A06AD

The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 9 other active substances share the group A06AD with this product:

Sodium hydrogen carbonate (9) · Lactulose (6) · Sodium bicarbonate (4) · Macrogol 4000 (2) · Magnesium sulphate dihydrate (1) · Citric acid (1) · Sodium sulphate anhydrous (1) · Sodium phosphate dibasic dihydrate (1) · Disodium phosphas dodecahydrate (1)

Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.

The licence holder

Norgine B.V. holds 11 products on the HPRA list, with 13 different active substances; 4 of the products are marked as marketed.

Shortages and approvals, every Friday

One email a week with ongoing EU and US medicine shortages, new EMA and FDA approvals and clinical trials recruiting in Ireland.

Free. Unsubscribe from any email with one click. See our privacy policy.

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.

How this page is built

The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.

This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 19 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.